SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

Aurinia Falls On Misinterpreted 'Downgrade'

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
somerssalt Member Profile
 
Followed By 1
Posts 16
Boards Moderated 0
Alias Born 05/03/17
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/14/2017 4:36:44 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/14/2017 4:05:25 PM
Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights "Business Wire" - 11/14/2017 4:00:00 PM
Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017 "Business Wire" - 11/6/2017 4:05:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 10/23/2017 5:11:55 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/20/2017 8:02:06 AM
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome "Business Wire" - 10/20/2017 8:00:00 AM
Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America "Business Wire" - 10/12/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/19/2017 4:10:24 PM
Aurinia to Host R&D Day and Webcast on October 20th in New York, NY "Business Wire" - 9/19/2017 4:01:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 4:07:10 PM
Aurinia to Webcast at Upcoming Investor Conferences "Business Wire" - 9/5/2017 1:05:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/10/2017 4:37:23 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/10/2017 4:31:45 PM
Aurinia Reports Second Quarter 2017 Financial Results, and Provides Operational Highlights "Business Wire" - 8/10/2017 4:30:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/13/2017 6:03:12 AM
Aurinia Resolves Temporary Non-Compliance with Nasdaq’s Audit Committee Composition Rule "Business Wire" - 7/12/2017 9:15:00 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 7/6/2017 6:08:52 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/22/2017 4:32:20 PM
Aurinia Announces Results of Annual General Meeting "Business Wire" - 6/22/2017 4:30:00 PM
Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC "Business Wire" - 6/21/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/16/2017 8:23:17 AM
Voclosporin Remission Data from the Phase IIb AURA-LV Study Highlighted at EULAR 2017 "Business Wire" - 6/16/2017 7:58:00 AM
Technical Snapshots for These Biotech Stocks -- Gilead Sciences, Aurinia Pharma, Esperion Therapeutics, and Alexion Pharma "PR Newswire (US)" - 6/8/2017 6:25:00 AM
Aurinia Presents Additional Data from Phase IIB AURA-LV Study, Demonstrating Stable Renal Function & Blood Pressure without E... "Business Wire" - 6/5/2017 11:27:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist